Torrent Pharmaceuticals share price
Torrent Pharmaceuticals is trading 1.89% upper at Rs 3,170.00 as compared to its last closing price. Torrent Pharmaceuticals has been trading in the price range of 3,210.25 & 3,120.55. Torrent Pharmaceuticals has given 34.94% in this year & -0.88% in the last 5 days.
Torrent Pharmaceuticals has TTM P/E ratio 54.44 as compared to the sector P/E of 29.10.There are 27 analysts who have initiated coverage on Torrent Pharmaceuticals. There are 5 analysts who have given it a strong buy rating & 13 analysts have given it a buy rating. 3 analysts have given the stock a sell rating.
The company posted a net profit of 457.00 Crores in its last quarter.
Listed peers of Torrent Pharmaceuticals include Zydus Lifesciences (2.64%), Dr Reddys Laboratories (-0.64%), Torrent Pharmaceuticals (1.89%) etc.
Torrent Pharmaceuticals has a 71.25% promoter holding & 28.75% public holding.The Mutual Fund holding in Torrent Pharmaceuticals was at 2.00% in 30 Jun 2024. The MF holding has increased from the last quarter. The FII holding in Torrent Pharmaceuticals was at 14.22% in 30 Jun 2024. The FII holding has increased from the last quarter.
Torrent Pharmaceuticals share price range
|
| ||||
|
| ||||
Torrent Pharmaceuticals share Key Metrics
Market Cap ( ₹ Cr.) | 1,05,295.50 | ||||||||||||||||||
|
|
Torrent Pharmaceuticals stock Analysis
1 Week | -0.88% |
3 Months | 17.73% |
6 Month | 25.80% |
YTD | 34.94% |
1 Year | 55.34% |
- 24%Moderate risk
- 24%Moderate risk
- 24%Moderate risk
- 24%Moderate risk
- 24%Moderate risk
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Ratings | Current | 1 W Ago | 1 M Ago | 3 M Ago |
---|---|---|---|---|
Strong Buy | 5 | 9 | 9 | 8 |
Buy | 13 | 12 | 12 | 12 |
Hold | 5 | 4 | 4 | 4 |
Sell | 3 | 2 | 2 | 2 |
Strong Sell | 1 | 0 | 0 | 0 |
Total | 27 | 27 | 27 | 26 |
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Torrent Pharmaceuticals share price news
Stocks to watch: HUL, Bajaj Finance, Axis Bank, REL, Asian Paints, DCM Shriram
5 min read .08:20 AM ISTBuy or sell: Vaishali Parekh recommends three stocks to buy today - July 3
3 min read .03:54 PM ISTShriram Finance market capitalisation crosses ₹1 lakh crore mark; stock jumps 4%
1 min read .05:18 PM ISTStocks to watch: Dr Reddy's, Torrent Pharma, Gensol, L&T Finance, Glenmark
2 min read .08:09 AM ISTTorrent Pharmaceuticals Financials
- INCOME
- BALANCE SHEET
- Cashflow
Period | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
Total Revenue | 10,728.00 | 9,620.15 | 8,508.04 | 8,004.83 |
Selling/ General/ Admin Expenses Total | 1,984.00 | 3,447.24 | 3,060.61 | 2,822.98 |
Depreciation/ Amortization | 808.00 | 702.03 | 661.93 | 657.31 |
Other Operating Expenses Total | 2,690.00 | 471.90 | 440.04 | 435.69 |
Total Operating Expense | 8,080.00 | 7,484.69 | 7,223.63 | 6,176.94 |
Operating Income | 2,648.00 | 2,135.46 | 1,284.41 | 1,827.89 |
Net Income Before Taxes | 2,352.00 | 1,847.16 | 1,225.91 | 1,526.26 |
Net Income | 1,656.00 | 1,245.23 | 777.18 | 1,251.88 |
Diluted Normalized EPS | 47.11 | 36.45 | 32.05 | 37.00 |
Torrent Pharmaceuticals forecast
Torrent Pharmaceuticals Technical
5 Day 3,152.28 |
10 Day 3,071.73 |
20 Day 2,979.39 |
50 Day 2,853.29 |
100 Day 2,736.86 |
300 Day 2,483.29 |
Torrent Pharmaceuticals Futures and Options
- FUTURES
- OPTIONS
Share Price
3,174.70INR66.40(2.14%)Open Interest
1.43 MINR-17.00 K(-1.31%)
- Open3,115.05
- High3,202.25
- Low3,103.35
- Prev Close3,108.30
- Contracts Traded1.61 K
- Turnover in (Rs Lakhs)12.77 K
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth
WhiteOak Capital Pharma and Healthcare Fund Regular Growth
Torrent Pharmaceuticals Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
Meeting Date | Purpose |
23-Jul-24 | Quarterly Results |
24-May-24 | Audited Results & Final Dividend |
02-Feb-24 | Quarterly Results & Interim Dividend |
23-Oct-23 | Quarterly Results |
07-Aug-23 | Quarterly Results |
30-May-23 | Audited Results & Final Dividend |
25-Jan-23 | Quarterly Results & Interim Dividend |
21-Oct-22 | Quarterly Results |
29-Jul-22 | Quarterly Results |
25-May-22 | Audited Results, Dividend & Bonus issue |
Meeting Date | Announcement On | Purpose |
29-Nov-23 | 26-Oct-23 | POM |
07-Aug-23 | 20-Jun-23 | AGM |
29-Jul-22 | 25-May-22 | AGM |
27-Jul-21 | 30-Jun-21 | AGM |
Announcement On | Record Date | Ex-Dividend | Dividend Value |
24-May-24 | 21-Jun-24 | 21-Jun-24 | 6 |
12-Jan-24 | 12-Feb-24 | 12-Feb-24 | 22 |
30-May-23 | 23-Jun-23 | 23-Jun-23 | 8 |
12-Jan-23 | 03-Feb-23 | 03-Feb-23 | 14 |
25-May-22 | 06-Jun-22 | 03-Jun-22 | 8 |
26-May-22 | 06-Jun-22 | 03-Jun-22 | 15 |
10-Jan-22 | 03-Feb-22 | 02-Feb-22 | 25 |
18-May-21 | 18-Jun-21 | 17-Jun-21 | 15 |
18-Jan-21 | 16-Feb-21 | 15-Feb-21 | 20 |
Announcement Date | Record Date | Ex-Bonus | Description |
25-May-22 | 11-Jul-22 | 08-Jul-22 | Bonus issue of equity shares in the ratio of 1:1 of Rs. 5/-. |
Torrent Pharmaceuticals Company profile
ABOUT Torrent Pharmaceuticals
- Industry Biotechnology & Drugs
- ISIN INE685A01028
- BSE Code 500420
- NSE Code TORNTPHARM
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain, gynecology, and dermatology. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its acne/facecare products brands include Clinmiskin, ACNEMOIST, TRACNILO and fash. The Company's hair/scalp care products brands include Proanagen, Perlice, Permite and NOSKURF. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim. The Company's primary channel of distribution is through the wholesale drug distributors, stockiest and retail pharmacies.
Torrent Pharmaceuticals Management
- Samir Mehta Executive Chairman of the Board
- Sudhir Menon Chief Financial Officer, Executive Director - Finance
- Chintan Trivedi Compliance Officer, Company Secretary
- Aman Mehta Whole-time Director
FAQs about Torrent Pharmaceuticals share price
Torrent Pharmaceuticals Quick Links
Torrent Pharmaceuticals Dividend Torrent Pharmaceuticals Bonus Torrent Pharmaceuticals News Torrent Pharmaceuticals AGM Torrent Pharmaceuticals Rights Torrent Pharmaceuticals Splits Torrent Pharmaceuticals Board Meetings Torrent Pharmaceuticals Key Metrics Torrent Pharmaceuticals Shareholdings Torrent Pharmaceuticals Profit Loss Torrent Pharmaceuticals Balance Sheet Torrent Pharmaceuticals Cashflow Torrent Pharmaceuticals Q1 Results Torrent Pharmaceuticals Q2 Results Torrent Pharmaceuticals Q3 Results Torrent Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks